← FDA DRUG APPROVALS

FDA ANDA · ANDA075090

ACYCLOVIR

Sponsor: REGCON HOLDINGS

APPLICATION
ANDA075090
TYPE
ANDA
ORIGINAL APPROVAL
1999-01-26
LATEST ACTION
2016-04-08
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

ACYCLOVIRPrescription
ACYCLOVIR 200MG · CAPSULE · ORAL

Approval history

2016-04-08Labeling · Supplement 11 · standardAP
2006-02-06Labeling · Supplement 6AP
2006-02-06Labeling · Supplement 7AP
2003-02-04Labeling · Supplement 3AP
1999-01-26OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →